IDEAYA Biosciences, Inc.
IDYA
$28.32
$0.110.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.52% | 36.10% | 330.11% | -46.84% | -82.40% |
| Total Depreciation and Amortization | 0.88% | 86.16% | 1.78% | 12.40% | 4.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.30% | 124.75% | 165.71% | 196.57% | 323,050.00% |
| Change in Net Operating Assets | 109.73% | -642.50% | 614.05% | -70.65% | 179.76% |
| Cash from Operations | -24.57% | 25.61% | 388.85% | -89.99% | -37.73% |
| Capital Expenditure | 27.29% | 69.78% | 90.81% | 31.86% | -0.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.78% | 50.41% | 313.54% | -33.01% | 123.01% |
| Cash from Investing | 49.03% | 50.52% | 308.46% | -33.02% | 122.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.45% | -22.63% | -99.89% | -96.92% | -92.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.48% | -22.63% | -99.89% | -96.92% | -92.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.44% | 41.18% | -15.17% | -120.51% | 193.72% |